MRD
0.032
540%
WYX
0.043
-36.8%
8IH
0.031
181.8%
GLA
0.024
-33.3%
MOM
0.002
100%
EZZ
2.25
-32.2%
RWL
0.225
55.2%
MYX
4.25
-30.4%
AMS
0.022
46.7%
LRD
0.02
-28.6%
BOC
1.46
46%
CNJ
0.008
-27.3%
ARV
0.01
42.9%
LRM
0.032
-27.3%
FRX
0.01
42.9%
TG6
0.205
-26.8%
NYR
0.81
39.7%
POL
0.92
-26.1%
ASH
0.22
37.5%
1AD
0.003
-25%
CNQ
0.555
33.7%
CCO
0.003
-25%
BIT
0.004
33.3%
DTR
0.285
-25%
FLC
0.125
33%
ARU
0.285
-24%
IKE
1.125
31.6%
SQX
0.145
-23.7%
BEL
0.026
30%
I88
0.38
-23.2%
SHO
0.04
29%
MDI
0.03
-23.1%
WBE
0.009
28.6%
YAR
0.01
-23.1%
MFD
0.465
27.4%
HRZ
0.054
-22.9%
DEV
0.14
27.3%
TMS
0.007
-22.2%
MDR
0.028
27.3%
LSR
0.032
-22%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CMP FDA clearance

Compumedics (ASX:CMP) announces the US FDA has cleared the Somfit device to be marketed in the USA. This marks the achievement of another significant strategic milestone for the Somfit technology platform in one of the world’s largest sleep markets https://www.compumedics.com.au/en/asx-announcements/somfit-update2-2/ #shorts